Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues.

Mutation and cancer: statistical study of retinoblastoma

Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612

Untitled work

(1968) · Medical Entomology and Zoology · Cited by 4,924

Manipulating the mouse embryo: A laboratory manual

Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460

Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells

Thomas, K. R., & Capecchi, M. R. (1987) · Cell · doi:10.1016/0092-8674(87)90646-5 · Cited by 2,355

Simplified mammalian DNA isolation procedure

Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., & Berns, A. J. M. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4293 · Cited by 1,497

Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients

Wallace, M. R., Marchuk, D. A., Andersen, L. B., Letcher, R., Odeh, H. M., Saulino, A. M., Fountain, J. W., Brereton, A., Nicholson, J. M., Mitchell, A. L., et al. (1990) · Science · doi:10.1126/science.2134734 · Cited by 1,478

Von Recklinghausen Neurofibromatosis

Riccardi, V. M. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112313052704 · Cited by 1,353

Neural Crest Cells Contribute to Normal Aorticopulmonary Septation

Kirby, M. L., Gale, T. F., & Stewart, D. E. (1983) · Science · doi:10.1126/science.6844926 · Cited by 1,118

The neurofibromatosis type 1 gene encodes a protein related to GAP

Xu, G., O'Connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., White, R., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90024-9 · Cited by 1,095

Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus

Viskochil, D. H., Buchberg, A. M., Xu, G., Cawthon, R., Stevens, J., Wolff, R. K., Culver, M., Carey, J. C., Copeland, N. G., Jenkins, N. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90252-a · Cited by 1,082

Parallels between tuberous sclerosis complex and neurofibromatosis 1: Common threads in the same tapestry

Gutmann, D. H. (1998) · Seminars in Pediatric Neurology · doi:10.1016/s1071-9091(98)80006-5 · Cited by 15

Modeling myeloid leukemia tumor suppressor gene inactivation in the mouse

Shannon, K., Beau, M. M. L., Largaespada, D. A., & Killeen, N. P. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0372 · Cited by 15

Signal transduction mechanisms in memory disorders

Shalin, S. C., Egli, R. E., Birnbaum, S. G., Roth, T. L., Levenson, J. M., & Sweatt, J. D. (2006) · Progress in brain research · doi:10.1016/s0079-6123(06)57003-7 · Cited by 14

Genetic Events and Signaling Mechanisms Underlying Schwann Cell Fate in Development and Cancer

Vasudevan, H. N., Lucas, C. G., Villanueva-Meyer, J. E., Theodosopoulos, P. V., & Raleigh, D. R. (2020) · Neurosurgery · doi:10.1093/neuros/nyaa455 · Cited by 17

Maximizing bone formation in posterior spine fusion using rhBMP‐2 and zoledronic acid in wild type and NF1 deficient mice

Bobyn, J. D., Rasch, A., Mikulec, K., Little, D. G., & Schindeler, A. (2014) · Journal of Orthopaedic Research® · doi:10.1002/jor.22628 · Cited by 14

Novel and Recurring Disease-Causing NF1 Variants in Two Chinese Families with Neurofibromatosis Type 1

Xiao, H., Yuan, L., Xu, H., Yang, Z., Huang, F., Song, Z. J., Yang, Y. X., Zeng, C. C., & Deng, H. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1128-9 · Cited by 14

XRASGRP2 is essential for blood vessel formation during Xenopus development

Suzuki, K. H., Takahashi, S., Haramoto, Y., Onuma, Y., Nagamine, K., Okabayashi, K., Hashizume, K., Iwanaka, T., & Asashima, M. (2009) · The International Journal of Developmental Biology · doi:10.1387/ijdb.092929ks · Cited by 14

HOMOZYGOUS INACTIVATION OF THE NF1 GENE IN BONE MARROW CELLS FROM CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 AND MALIGNANT MYELOID DISORDERS

Ide, L. U. S., Aylor, R. T., Uce, M. I. L., & Hannon, K. E. S. (1997) · Cited by 14

Double‐Outlet Ventricle

Lopez, L., & Geva, T. (2016) · doi:10.1002/9781118742440.ch25 · Cited by 14

Myeloid Leukemia: Disease Genes and Mouse Models

Copeland, N. G., & Jenkins, N. A. (1999) · KARGER eBooks · doi:10.1159/000062003 · Cited by 14

Molecular Determinants of Cardiac Development and Congenital Disease

Harvey, R. P. (2002) · Elsevier eBooks · doi:10.1016/b978-012597951-1/50020-2 · Cited by 14

The role of RalA in biology and therapy of ovarian cancer.

Wang, K., Terai, K., Peng, W., Rouyanian, A., Liu, J., Roby, K. F., Al, W., Ezzeldin, M., Larson, J. A., Ra, W., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1435 · Cited by 13

Genetic enhancement of Ras-ERK pathway does not aggravate L-DOPA-induced dyskinesia in mice but prevents the decrease induced by lovastatin

Ruiz‐DeDiego, I., Fasano, S., Solís, Ó., García-Montes, J.-R., Brea, J. M., Loza, M. I., Brambilla, R., & Moratalla, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-33713-3 · Cited by 13

Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 17

Mund, J. A., Park, S.-J., Smith, A. E., He, Y., Jiang, L., Hawley, E., Roberson, M. J., Mitchell, D. K., Abu-Sultanah, M., Yuan, J., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010981 · Cited by 14

Genetic Architecture of Declarative Memory

Bearden, C. E., Karlsgodt, K. H., Bachman, P., van Erp, T. G. M., Winkler, A. M., & Glahn, D. C. (2011) · The Neuroscientist · doi:10.1177/1073858411415113 · Cited by 13

Shared developmental gait disruptions across two mouse models of neurodevelopmental disorders

Rahn, R. M., Weichselbaum, C. T., Gutmann, D. H., Dougherty, J. D., & Maloney, S. E. (2021) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-021-09359-0 · Cited by 13

Regulation of neurofibromin expression in rat sciatic nerve and cultured Schwann cells

Wrabetz, L. G., Feltri, M. L., Kim, H., Daston, M. M., Kamholz, J. A., Scherer, S. S., & Ratner, N. (1995) · Glia · doi:10.1002/glia.440150104 · Cited by 13

Variation of iron loading expression in C282Y homozygous haemochromatosis probands and sib pairs

Mura, C., Gac, G. L., Scotet, V., Raguenes, O., Mercier, A.-Y., & Férec, C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.9.632 · Cited by 13

Aetiology of spinal deformities in neurofibromatosis 1: new hypotheses

Abdel-Wanis, M. E.-S., & Kawahara, N. (2001) · Medical Hypotheses · doi:10.1054/mehy.2000.1232 · Cited by 13

Cell Lineages and Tissue Boundaries in Cardiac Arterial and Venous Poles

Ausoni, S., & Sartore, S. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.3.312 · Cited by 14

The Cardiac Cell Cycle

MacLellan, W. R., & Schneider, M. D. (1999) · Elsevier eBooks · doi:10.1016/b978-012329860-7/50025-8 · Cited by 13

Nf1 mutation disrupts activity-dependent oligodendroglial plasticity and motor learning in mice

Pan, Y., Hysinger, J. D., Yalçın, B., Lennon, J., Byun, Y. G., Raghavan, P., Schindler, N. F., Anastasaki, C., Chatterjee, J., Ni, L., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01654-y · Cited by 13

RASopathies – what they reveal about RAS/MAPK signaling in skeletal muscle development

Rauen, K. A., & Tidyman, W. E. (2024) · Disease Models & Mechanisms · doi:10.1242/dmm.050609 · Cited by 12

Unraveling neuronal and metabolic alterations in neurofibromatosis type 1

Botero, V., & Tomchik, S. M. (2024) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-024-09565-6 · Cited by 12

The role of neurofibromin and melatonin in pathogenesis of pseudarthrosis after spinal fusion for neurofibromatous scoliosis

Abdel-Wanis, M. E.-S., & Kawahara, N. (2002) · Medical Hypotheses · doi:10.1054/mehy.2001.1467 · Cited by 12

Developmental dosing with a MEK inhibitor (PD0325901) rescues myopathic features of the muscle-specific but not limb-specific Nf1 knockout mouse

Summers, M. A., Vasiljevski, E. R., Mikulec, K., Peacock, L., Little, D. G., & Schindeler, A. (2018) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2018.02.009 · Cited by 12

Recent progress in the molecular genetics of congenital heart defects

Belmont, J. W. (1998) · Clinical Genetics · doi:10.1111/j.1399-0004.1998.tb03685.x · Cited by 12

Focal segmental glomerulosclerosis in association with neurofibromatosis type 1: a case report and proposed molecular pathways

Afshinnia, F., Vega-Warner, V., & Killen, P. (2013) · Clinical Kidney Journal · doi:10.1093/ckj/sft010 · Cited by 12

Genetics of Neurofibromatosis 1-Associated Peripheral Nerve Sheath Tumors

Stephens, K. G. (2003) · Cancer Investigation · doi:10.1081/cnv-120025093 · Cited by 12

Animal models of congenital defects in the ventriculoarterial connection of the heart

Ya, J., Schilham, M. W., Clevers, H. C., Moorman, A. F. M., & Lamers, W. H. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050140 · Cited by 12

Brain injury drives optic glioma formation through neuron-glia signaling

Chatterjee, J., Koleske, J. P., Chao, A., Sauerbeck, A. D., Chen, J., Qi, X., Ouyang, M., Boggs, L. G., Idate, R., Marquez, L. I. M. Y., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01735-w · Cited by 11

Neurofibromatosis tipo 1 (NF1) y su diagnóstico molecular como estrategia del diagnóstico diferencial y a edades tempranas

Gomez, M. P. A., & Batista, O. I. (2015) · Revista médica de Chile · doi:10.4067/s0034-98872015001000011 · Cited by 13

Phenotypic characterization of transgenic mice harboring Nf1+/− or Nf1−/− osteoclasts in otherwise Nf1+/+ background

Alanne, M. H., Siljamäki, E., Peltonen, S. A., Väänänen, K., Windle, J. J., Parada, L. F., Määttä, J. A., & Peltonen, J. T. K. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24088 · Cited by 12

Particularly Interesting Cysteine- and Histidine-Rich Protein in Cardiac Development and Remodeling

Liang, X., Sun, Y., & Chen, J. (2009) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181c5e31d · Cited by 11

Murine tumor suppressor models

Venkatachalam, S., & Donehower, L. A. (1998) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(98)00018-9 · Cited by 11

The Heart in Ras-MAPK Pathway Disorders

Digilio, M. C., Marino, B., Sárközy, A., Versacci, P., & Dallapiccola, B. (2008) · Monographs in human genetics · doi:10.1159/000164847 · Cited by 10

A new twist in neuroendocrine tumor research: Pacak-Zhuang syndrome, HIF-2α as the major player in its pathogenesis and future therapeutic options

Jochmanová, I., & Lazúrová, I. (2014) · Biomedical Papers · doi:10.5507/bp.2014.021 · Cited by 10

Blockade of Serotonin 5-HT6 Receptor Constitutive Activity Alleviates Cognitive Deficits in a Preclinical Model of Neurofibromatosis Type 1

Doucet, E., Grychowska, K., Zajdel, P., Bockaert, J., Marin, P., & Bécamel, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810178 · Cited by 10

Physiological and genomic consequences of adrenergic deficiency during embryonic/fetal development in mice: impact on retinoic acid metabolism

Osuala, K. O., Baker, C. N., Nguyen, H., Martinez, C., Weinshenker, D., & Ebert, S. N. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00180.2011 · Cited by 10

Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma

Ricker, C. A., Pan, Y., Gutmann, D. H., & Keller, C. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00259 · Cited by 10

Microdeletion in the FMR-1 gene: an apparent null allele using routine clinical PCR amplification

Hegde, M., Chong, B., Fawkner, M., Lambiris, N., Peters, H., Kenneson, A., Warren, S. T., Love, D. R., & McGaughran, J. M. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.9.624 · Cited by 10

A high-resolution map of the chromosomal region surrounding the nude gene

Blackburn, C. C., Griffith, J., & Morahan, G. (1995) · Genomics · doi:10.1016/0888-7543(95)80215-8 · Cited by 10

Motor deficits and neurofibromatosis type 1 (NF1)‐associated MRI impairments in a mouse model of NF1

Robinson, A., Kloog, Y., Stein, R., & Assaf, Y. (2010) · NMR in Biomedicine · doi:10.1002/nbm.1546 · Cited by 9

Biofabrication of a three dimensional human‐based personalized neurofibroma model

Roy, V., Lamontagne, R., Talagas, M., Touzel‐Deschênes, L., Khuong, H. T., Saïkali, S., Dupré, N., & Gros‐Louis, F. (2021) · Biotechnology Journal · doi:10.1002/biot.202000250 · Cited by 9

Down-regulated Six2 by knockdown of neurofibromin results in apoptosis of metanephric mesenchyme cells in vitro

Zhou, P., Chen, T., Fang, Y., Wang, H., Li, M., Ma, P., He, L., Li, Q., Liu, T., Yang, X., et al. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-1971-0 · Cited by 9

Genetic Predispositions and Childhood Cancer

Shannon, K. (1998) · Environmental Health Perspectives · doi:10.1289/ehp.98106801 · Cited by 9

Primary Schwann Cell Cultures

Kim, H. A., & Maurel, P. (2009) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-60761-292-6_15 · Cited by 9

Segmental Regulation of Cardiac Development by the Basic Helix-Loop-Helix Transcription Factors dHAND and eHAND

Srivastava, D. (1999) · Elsevier eBooks · doi:10.1016/b978-012329860-7/50011-8 · Cited by 9

Regulation of Cardiac Development by Receptor Tyrosine Kinases

Tessarollo, L., & Hempstead, B. L. (1998) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(97)00119-9 · Cited by 9

Bone development in neurofibromatosis 1

Abdel-Wanis, M. E.-S., & Kawahara, N. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(02)00225-6 · Cited by 9

Transgenic mice as research tools in neurocarcinogenesis

Rovigatti, U., Afanasyeva, T., Brandner, S., Hainfellner, J. A., Kiess, M., Maddalena, A. S., Malin, G., Rülicke, T., Steinbach, J. P., Weissenberger, J., et al. (1998) · Journal of NeuroVirology · doi:10.3109/13550289809114516 · Cited by 9

The Contribution of Oxidative Stress to NF1-Altered Tumors

Kuhn, E., Natacci, F., Corbo, M., Pisani, L., Ferrero, S., Bulfamante, G., & Gambini, D. (2023) · Antioxidants · doi:10.3390/antiox12081557 · Cited by 10

Neurofibromin 1 expression is negatively correlated with malignancy and prognosis of epithelial ovarian cancer.

Qiao, G., Xuchun, J., Zhang, Y., & Chen, B. (2019) · Europe PMC (PubMed Central) · Cited by 8

Cardiac abnormalities detected by doppler imaging in patients with neurofibromatosis type 1

Tedesco, M. A., Salvo, G. D., Natale, F., Caputo, S., Calabrese, E., Grassia, C., Ratti, G., Iarussi, D., Iacono, A., & Lama, G. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02062-8 · Cited by 8

Spontaneous rupture of a dissecting aneurysm in the superior rectal artery of a patient with neurofibromatosis type 1: a case report

Makino, K., Kurita, N., Kanai, M., & Kirita, M. (2013) · Journal of Medical Case Reports · doi:10.1186/1752-1947-7-249 · Cited by 8

Tumor Suppressor Genes

Cheng, Y. (2012) · InTech eBooks · doi:10.5772/1337 · Cited by 9

Genetics of Hydrocephalus

Dirks, P. B. (2005) · Springer eBooks · doi:10.1007/978-88-470-2121-1_1 · Cited by 8

Tumor Suppressor Gene Regulation of Cell Growth: Recent Insights into Neurofibromatosis 1 and 2 Gene Function

Uhlmann, E. J., & Gutmann, D. H. (2001) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:34:1:61 · Cited by 8

The Neurofibromatosis Type 1 (NF1) Tumor Suppressor Gene and Myeloid Leukemia

Largaespada, D. A., Brannan, C. I., Shaughnessy, J. D., Jenkins, N. A., & Copeland, N. G. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-85232-9_23 · Cited by 8

Birth Characteristics Among Children Diagnosed with Neurofibromatosis Type 1 and Tuberous Sclerosis

Tettamanti, G., Mogensen, H., Kampitsi, C., Nordgren, A., & Feychting, M. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.08.009 · Cited by 7

Two pathogenic NF1 gene mutations identified in DNA from a child with mild phenotype

Terzi, Y. K., Sirin, B., Hosgor, G., Serdaroğlu, E., Anlar, B., Aysun, S., & Ayter, Ş. (2011) · Child s Nervous System · doi:10.1007/s00381-011-1648-x · Cited by 7

La neurofibromatose 1

Wolkenstein, P. (2001) · médecine/sciences · doi:10.1051/medsci/200117111158 · Cited by 7

Mouse Models of Inherited Cancer Syndromes

Jahid, S., & Lipkin, S. M. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.011 · Cited by 7

Mice lacking neurofibromin develop gastric hyperplasia

Lin, L., Chen, J., Richardson, J. A., & Parada, L. F. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00007.2009 · Cited by 7

Neurofibromatosis Type 1

McLaughlin, M. E., & Jacks, T. (2003) · Humana Press eBooks · doi:10.1385/1-59259-328-3:223 · Cited by 7

Isolation and Expansion of Schwann Cells from Transgenic Mouse Models

Kim, J. H., & Kim, H. A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7649-2_3 · Cited by 7

Establishing the anatomic hallmarks of congenitally malformed hearts

Anderson, R. H., Webb, S., & Brown, N. A. (1996) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(95)00123-9 · Cited by 7

Animal models for human contiguous gene syndromes and other genomic disorders

Walz, K., Fonseca, P., & Lupski, J. R. (2004) · Genetics and Molecular Biology · doi:10.1590/s1415-47572004000300001 · Cited by 7

Transgenic mice: What are we learning about gene function and neurological disease?

Longo, F. M. (1995) · The Neuroscientist · doi:10.1177/107385849500100601 · Cited by 7

Neurofibromatosis type 1: II. Answers from animal models

Lakkis, M. M., & Tennekoon, G. I. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1142 · Cited by 7

Analyses of Tumor-Suppressor Genes in Germline Mouse Models of CancerPreprint

Wang, J., & Abate-Shen, C. T. (2014) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top069773 · Cited by 7

The impact of RAS on cell differentiation in health and disease

Duval, C. J., Bottone, S., Schaffner‐Reckinger, E., & Abankwa, D. (2025) · Biochemical Journal · doi:10.1042/bcj20253364 · Cited by 6

Rationale for haploinsufficiency correction therapy in neurofibromatosis type 1

Frost, M., Serra, E., Viskochil, D. H., Korf, B. R., Mattson-Hoss, M. K., Croston, G. E., & Sarnoff, H. (2022) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2022.14 · Cited by 6

Nf1 in heart development: a potential causative gene for congenital heart disease: a narrative review

Wang, D., Wen, X., Xu, L., Chen, Q.-X., Yan, T.-X., Xiao, H., & Xu, X. (2023) · Physiological Genomics · doi:10.1152/physiolgenomics.00024.2023 · Cited by 6

Crk and Crkl Are Required in the Endocardial Lineage for Heart Valve Development

Wu, B., Wu, B., Benkaci, S., Shi, L., Lu, P., Park, T., Morrow, B. E., Wang, Y., & Zhou, B. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.029683 · Cited by 6

Left ventricular noncompaction and orthodromic atrioventricular tachycardia observed in a patient with neurofibromatosis type 1

Ibarrola, M., Pérez‐Riera, A. R., & Gonzalez, M. D. (2019) · Oxford Medical Case Reports · doi:10.1093/omcr/omz021 · Cited by 6

Induction of mitotic catastrophe by PKC inhibition in Nf1-deficient cells

Zhou, X., Kim, S., Shen, L., Lee, H., & Chen, C. (2014) · Cell Cycle · doi:10.4161/cc.29297 · Cited by 6

Mouse Models of Frequently Mutated Genes in Acute Myeloid Leukemia

Mohanty, S., & Heuser, M. (2021) · Cancers · doi:10.3390/cancers13246192 · Cited by 6

An Assessment of the Therapeutic Landscape for the Treatment of Heart Disease in the RASopathies

Yi, J.-S., Perla, S., & Bennett, A. M. (2022) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-022-07324-0 · Cited by 6

Hereditary Cancer and Developmental Abnormalities

Ben‐Yosef, T., & Benvenisty, N. (1999) · Neonatology · doi:10.1159/000014188 · Cited by 6

Gene‐Targeting Approaches in the Study of Cellular Processes Involved in Growth or Differentiation

Yamada, G., Sugimura, K., & Stuart, E. T. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.00739.x · Cited by 6

Visual Deficits and Diagnostic and Therapeutic Strategies for Neurofibromatosis Type 1: Bridging Science and Patient-Centered Care

Miyagishima, K. J., Qiao, F., Stasheff, S. F., & Nadal-Nicolás, F. M. (2024) · Vision · doi:10.3390/vision8020031 · Cited by 7

Cell of Origin and the Contribution of Microenvironment in NF1 Tumorigenesis and Therapeutic Implications

Buchstaller, J., Clapp, D. W., Parada, L. F., & Zhu, Y. (2012) · Springer eBooks · doi:10.1007/978-3-642-32864-0_36 · Cited by 5

Translational/Clinical Studies in Children and Adults with Neurofibromatosis Type 1

Korf, B. R., Widemann, B. C., Acosta, M. T., & Packer, R. J. (2012) · Springer eBooks · doi:10.1007/978-3-642-32864-0_40 · Cited by 5

PKCε-dependent H-Ras activation encompasses the recruitment of the RasGEF SOS1 and of the RasGAP neurofibromin in the lipid rafts of embryonic neurons

Karouzaki, S., Peta, C., Tsirimonaki, E., & Mangoura, D. A. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104582 · Cited by 5

Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype

Wiesner, S. M., Geurts, J. L., Diers, M. D., Bergerson, R. J., Hasz, D. E., Morgan, K. J., & Largaespada, D. A. (2011) · American Journal of Hematology · doi:10.1002/ajh.22035 · Cited by 5

RhoA Regulation of Cardiomyocyte Differentiation

Kaarbø, M., Crane, D. I., & Murrell, W. G. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/491546 · Cited by 5

Perspectives Series: Molecular Medicine in Genetically Engineered Animals

Rajewsky, K., Gu, H., Kühn, R., Müller, W., Roes, J., & Schwenk, F. (1996) · Cited by 5

Double‐Outlet Ventricle

Lopez, L. (2009) · doi:10.1002/9781444306309.ch25 · Cited by 5

Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic

Logiacco, F., Grzegorzek, L. C., Cordell, E., Popp, O., Mertins, P., Gutmann, D. H., Kettenmann, H., & Semtner, M. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01525-w · Cited by 4

The Nf1–/+; Trp53–/+cis Mouse Model of Anaplastic Astrocytoma and Secondary Glioblastoma: Dissecting Genetic Susceptibility to Brain Cancer

Reilly, K. M. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-553-8_6 · Cited by 4

Genetically modified mouse models in cancer studies

Santos, J., Fernández‐Navarro, P., Villa‐Morales, M., González-Sánchez, L., & Fernández‐Piqueras, J. (2008) · Clinical & Translational Oncology · doi:10.1007/s12094-008-0292-8 · Cited by 4

A mild mutator phenotype arises in a mouse model for malignancies associated with neurofibromatosis type 1

Garza, R. J. D. L., Hudson, R. A., McMahan, C. A., Walter, C. A., & Vogel, K. S. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.11.031 · Cited by 4

Experimental therapeutic approaches to peripheral nerve tumors

Riley, J. R., Spiotta, A. M., & Boulis, N. M. (2007) · Neurosurgical FOCUS · doi:10.3171/foc.2007.22.6.3 · Cited by 4

Signaling Pathways in Valve Formation

Grego‐Bessa, J., Pérez-Pomares, J. M., & de la Pompa, J. L. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-381332-9.00019-0 · Cited by 5

Mechanistic and Preclinical Insights from Mouse Models of Hematologic Cancer Characterized by Hyperactive RasPreprint

Wandler, A. M., & Shannon, K. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031526 · Cited by 4

Definition of germ layer cell lineage alternative splicing programs reveals a critical role for Quaking in specifying cardiac cell fatePreprint

Fagg, W. S., Liu, N., Braunschweig, U., de Castro, K. L. P., Chen, X., Ditmars, F. S., Widen, S. G., Donohue, J. P., Módis, K., Russell, W. K., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.22.423880 · Cited by 4

Shared and divergent alteration of whole-brain connectivity and sensory deficits in multiple autism mouse models

Hsu, T.-T., Chen, C.-P., Lin, M.-H., Hung, T.-E., Huang, T., Wang, C.-Y., & Hsueh, Y. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03340-2 · Cited by 3

Neurofibromin 1 controls metabolic balance and Notch-dependent quiescence of murine juvenile myogenic progenitors

Wei, X., Rigopoulos, A., Lienhard, M., Pöhle‐Kronawitter, S., Kotsaris, G., Franke, J., Berndt, N., Mejedo, J. O., Wu, H., Boerno, S. T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45618-z · Cited by 4

Genetics and current research models of Mendelian tumor predisposition syndromes with ocular involvement

Lozano, L. P., Jensen, R., Jennisch, M. K., Pandala, N. G., Jamshidi, F., Boldt, H. C., Tucker, B. A., & Binkley, E. M. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101359 · Cited by 3

Regulating Heart Development: The Role ofNf1

Gitler, A. D., & Epstein, J. A. (2003) · Cell Cycle · doi:10.4161/cc.2.2.299 · Cited by 10

Loss of neurofibromin Ras-GAP activity enhances the formation of cardiac blood islands in murine embryos

Yzaguirre, A. D., Padmanabhan, A., de Groh, E. D., Engleka, K. A., Li, J., Speck, N. A., & Epstein, J. A. (2015) · eLife · doi:10.7554/elife.07780 · Cited by 19

The neurofibromin GAP-related domain rescues endothelial but not neural crest development in Nf1-/- mice

Ismat, F. A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28341 · Cited by 55

CREATING A MOUSE MODEL OF NEUROFIBROMATOSIS TYPE I:

Shih, T. S., & Jacks, T. (2016)

Nf1 has an essential role in endothelial cells

Gitler, A. D., Zhu, Y., Ismat, F. A., Lu, M. M., Yamauchi, Y., Parada, L. F., & Epstein, J. A. (2002) · Nature Genetics · doi:10.1038/ng1059 · Cited by 173